《新股表现》万宝盛华(02180.HK)暗盘收10.92元高上市价10.3%
根据辉立交易平台显示,明天挂牌的万宝盛华(02180.HK)暗盘开报10.9元,最多涨31.3%高见13元,收报10.92元,较上市价9.9元,高10.3%或1.02元;成交232万股,涉资2,570万元。不计手续费,每手250股账面赚255元。
万宝盛华为人力资源解决方案供应商。是次上市共发售5,000万股,其中10%公开发售获约3.7倍超购,股份以招股范围(9.9-12.6元)下限定价,料集资净额4.516亿元,主要用作进一步扩大业务规模和市场份额、投资研发、增强技术能力与发展数字人力资源平台、寻求策略性并购活动,以及进一步投资品牌建设和数字营销等。上市独家保荐人华泰金融香港。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.